Selected research
Industry Growth & Trends
Global Hydromorphone Hydrochloride Injection Industry Growth and Trends Forecast to 2032
Market perspective
The global Hydromorphone Hydrochloride Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Hydromorphone Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Hydromorphone Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Hydromorphone Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Hydromorphone Hydrochloride Injection include Akorn, Hikma, Purdue, Baxter, Fresenius Kabi, Pfizer, Sandoz, Teva and Yichang Renfu Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Hydromorphone Hydrochloride Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Hydromorphone Hydrochloride Injection market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hydromorphone Hydrochloride Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hydromorphone Hydrochloride Injection.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Hydromorphone Hydrochloride Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Hydromorphone Hydrochloride Injection Market by Company
Akorn
Hikma
Purdue
Baxter
Fresenius Kabi
Pfizer
Sandoz
Teva
Yichang Renfu Pharmaceutical
Hydromorphone Hydrochloride Injection Segment by Type
1mg/ml
2mg/ml
10mg/ml
Hydromorphone Hydrochloride Injection Segment by Application
Clinics
Hospital
Recovery Center
Hydromorphone Hydrochloride Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydromorphone Hydrochloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hydromorphone Hydrochloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydromorphone Hydrochloride Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hydromorphone Hydrochloride Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Hydromorphone Hydrochloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1mg/ml
- 2mg/ml
- 10mg/ml
Applications
- Clinics
- Hospital
- Recovery Center
Companies covered
- Akorn
- Hikma
- Purdue
- Baxter
- Fresenius Kabi
- Pfizer
- Sandoz
- Teva
- Yichang Renfu Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Hydromorphone Hydrochloride Injection Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Hydromorphone Hydrochloride Injection Sales Estimates and Forecasts (2021-2032)
- 1.3 Hydromorphone Hydrochloride Injection Market by Type
- 1.3.1 1mg/ml
- 1.3.2 2mg/ml
- 1.3.3 10mg/ml
- 1.4 Global Hydromorphone Hydrochloride Injection Market Size by Type
- 1.4.1 Global Hydromorphone Hydrochloride Injection Market Size Overview by Type (2021-2032)
- 1.4.2 Global Hydromorphone Hydrochloride Injection Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Hydromorphone Hydrochloride Injection Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Hydromorphone Hydrochloride Injection Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Hydromorphone Hydrochloride Injection Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Hydromorphone Hydrochloride Injection Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Hydromorphone Hydrochloride Injection Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Hydromorphone Hydrochloride Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Hydromorphone Hydrochloride Injection Industry Trends
- 2.2 Hydromorphone Hydrochloride Injection Industry Drivers
- 2.3 Hydromorphone Hydrochloride Injection Industry Opportunities and Challenges
- 2.4 Hydromorphone Hydrochloride Injection Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Hydromorphone Hydrochloride Injection Revenue (2021-2026)
- 3.2 Global Top Players by Hydromorphone Hydrochloride Injection Sales (2021-2026)
- 3.3 Global Top Players by Hydromorphone Hydrochloride Injection Price (2021-2026)
- 3.4 Global Hydromorphone Hydrochloride Injection Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Hydromorphone Hydrochloride Injection Major Company Production Sites & Headquarters
- 3.6 Global Hydromorphone Hydrochloride Injection Company, Product Type & Application
- 3.7 Global Hydromorphone Hydrochloride Injection Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Hydromorphone Hydrochloride Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Hydromorphone Hydrochloride Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Hydromorphone Hydrochloride Injection Tier 1, Tier 2, and Tier 3
4 Hydromorphone Hydrochloride Injection Regional Status and Outlook
- 4.1 Global Hydromorphone Hydrochloride Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Hydromorphone Hydrochloride Injection Historic Market Size by Region
- 4.2.1 Global Hydromorphone Hydrochloride Injection Sales in Volume by Region (2021-2026)
- 4.2.2 Global Hydromorphone Hydrochloride Injection Sales in Value by Region (2021-2026)
- 4.2.3 Global Hydromorphone Hydrochloride Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Hydromorphone Hydrochloride Injection Forecasted Market Size by Region
- 4.3.1 Global Hydromorphone Hydrochloride Injection Sales in Volume by Region (2027-2032)
- 4.3.2 Global Hydromorphone Hydrochloride Injection Sales in Value by Region (2027-2032)
- 4.3.3 Global Hydromorphone Hydrochloride Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hydromorphone Hydrochloride Injection by Application
- 5.1 Hydromorphone Hydrochloride Injection Market by Application
- 5.1.1 Clinics
- 5.1.2 Hospital
- 5.1.3 Recovery Center
- 5.2 Global Hydromorphone Hydrochloride Injection Market Size by Application
- 5.2.1 Global Hydromorphone Hydrochloride Injection Market Size Overview by Application (2021-2032)
- 5.2.2 Global Hydromorphone Hydrochloride Injection Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Hydromorphone Hydrochloride Injection Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Hydromorphone Hydrochloride Injection Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Hydromorphone Hydrochloride Injection Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Hydromorphone Hydrochloride Injection Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Hydromorphone Hydrochloride Injection Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Hydromorphone Hydrochloride Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Akorn
- 6.1.1 Akorn Company Information
- 6.1.2 Akorn Business Overview
- 6.1.3 Akorn Hydromorphone Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Akorn Hydromorphone Hydrochloride Injection Product Portfolio
- 6.1.5 Akorn Recent Developments
- 6.2 Hikma
- 6.2.1 Hikma Company Information
- 6.2.2 Hikma Business Overview
- 6.2.3 Hikma Hydromorphone Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Hikma Hydromorphone Hydrochloride Injection Product Portfolio
- 6.2.5 Hikma Recent Developments
- 6.3 Purdue
- 6.3.1 Purdue Company Information
- 6.3.2 Purdue Business Overview
- 6.3.3 Purdue Hydromorphone Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Purdue Hydromorphone Hydrochloride Injection Product Portfolio
- 6.3.5 Purdue Recent Developments
- 6.4 Baxter
- 6.4.1 Baxter Company Information
- 6.4.2 Baxter Business Overview
- 6.4.3 Baxter Hydromorphone Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Baxter Hydromorphone Hydrochloride Injection Product Portfolio
- 6.4.5 Baxter Recent Developments
- 6.5 Fresenius Kabi
- 6.5.1 Fresenius Kabi Company Information
- 6.5.2 Fresenius Kabi Business Overview
- 6.5.3 Fresenius Kabi Hydromorphone Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Fresenius Kabi Hydromorphone Hydrochloride Injection Product Portfolio
- 6.5.5 Fresenius Kabi Recent Developments
- 6.6 Pfizer
- 6.6.1 Pfizer Company Information
- 6.6.2 Pfizer Business Overview
- 6.6.3 Pfizer Hydromorphone Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Pfizer Hydromorphone Hydrochloride Injection Product Portfolio
- 6.6.5 Pfizer Recent Developments
- 6.7 Sandoz
- 6.7.1 Sandoz Company Information
- 6.7.2 Sandoz Business Overview
- 6.7.3 Sandoz Hydromorphone Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Sandoz Hydromorphone Hydrochloride Injection Product Portfolio
- 6.7.5 Sandoz Recent Developments
- 6.8 Teva
- 6.8.1 Teva Company Information
- 6.8.2 Teva Business Overview
- 6.8.3 Teva Hydromorphone Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Teva Hydromorphone Hydrochloride Injection Product Portfolio
- 6.8.5 Teva Recent Developments
- 6.9 Yichang Renfu Pharmaceutical
- 6.9.1 Yichang Renfu Pharmaceutical Company Information
- 6.9.2 Yichang Renfu Pharmaceutical Business Overview
- 6.9.3 Yichang Renfu Pharmaceutical Hydromorphone Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Yichang Renfu Pharmaceutical Hydromorphone Hydrochloride Injection Product Portfolio
- 6.9.5 Yichang Renfu Pharmaceutical Recent Developments
7 North America by Country
- 7.1 North America Hydromorphone Hydrochloride Injection Sales by Country
- 7.1.1 North America Hydromorphone Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Hydromorphone Hydrochloride Injection Sales by Country (2021-2026)
- 7.1.3 North America Hydromorphone Hydrochloride Injection Sales Forecast by Country (2027-2032)
- 7.2 North America Hydromorphone Hydrochloride Injection Market Size by Country
- 7.2.1 North America Hydromorphone Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Hydromorphone Hydrochloride Injection Market Size by Country (2021-2026)
- 7.2.3 North America Hydromorphone Hydrochloride Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Hydromorphone Hydrochloride Injection Sales by Country
- 8.1.1 Europe Hydromorphone Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Hydromorphone Hydrochloride Injection Sales by Country (2021-2026)
- 8.1.3 Europe Hydromorphone Hydrochloride Injection Sales Forecast by Country (2027-2032)
- 8.2 Europe Hydromorphone Hydrochloride Injection Market Size by Country
- 8.2.1 Europe Hydromorphone Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Hydromorphone Hydrochloride Injection Market Size by Country (2021-2026)
- 8.2.3 Europe Hydromorphone Hydrochloride Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Hydromorphone Hydrochloride Injection Sales by Country
- 9.1.1 Asia-Pacific Hydromorphone Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Hydromorphone Hydrochloride Injection Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Hydromorphone Hydrochloride Injection Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Hydromorphone Hydrochloride Injection Market Size by Country
- 9.2.1 Asia-Pacific Hydromorphone Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Hydromorphone Hydrochloride Injection Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Hydromorphone Hydrochloride Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Hydromorphone Hydrochloride Injection Sales by Country
- 10.1.1 South America Hydromorphone Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Hydromorphone Hydrochloride Injection Sales by Country (2021-2026)
- 10.1.3 South America Hydromorphone Hydrochloride Injection Sales Forecast by Country (2027-2032)
- 10.2 South America Hydromorphone Hydrochloride Injection Market Size by Country
- 10.2.1 South America Hydromorphone Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Hydromorphone Hydrochloride Injection Market Size by Country (2021-2026)
- 10.2.3 South America Hydromorphone Hydrochloride Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Hydromorphone Hydrochloride Injection Sales by Country
- 11.1.1 Middle East and Africa Hydromorphone Hydrochloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Hydromorphone Hydrochloride Injection Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Hydromorphone Hydrochloride Injection Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Hydromorphone Hydrochloride Injection Market Size by Country
- 11.2.1 Middle East and Africa Hydromorphone Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Hydromorphone Hydrochloride Injection Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Hydromorphone Hydrochloride Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Hydromorphone Hydrochloride Injection Value Chain Analysis
- 12.1.1 Hydromorphone Hydrochloride Injection Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Hydromorphone Hydrochloride Injection Production Mode & Process
- 12.2 Hydromorphone Hydrochloride Injection Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Hydromorphone Hydrochloride Injection Distributors
- 12.2.3 Hydromorphone Hydrochloride Injection Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst